Franklin Resources
CGON icon

Franklin Resources’s CG Oncology CGON Stock Holding History

Franklin Resources’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$93.3M Sell
1,312,880
-194,125
-13% -$12.7M 0.02% 480
2026
Q1 		$102M Sell
1,507,005
-54,569
-3% -$3.09M 0.03% 433
2025
Q4 		$64.8M Buy
1,561,574
+92,271
+6% +$3.82M 0.02% 557
2025
Q3 		$59.2M Sell
1,469,303
-17,536
-1% -$510K 0.01% 586
2025
Q2 		$38.7M Buy
1,486,839
+167,905
+13% +$4.05M 0.01% 709
2025
Q1 		$32.3M Buy
1,318,934
+43,043
+3% +$1.21M 0.01% 749
2024
Q4 		$36.6M Buy
1,275,891
+45,698
+4% +$1.56M 0.01% 713
2024
Q3 		$46.2M Buy
1,230,193
+100,106
+9% +$3.51M 0.01% 634
2024
Q2 		$35.7M Buy
1,130,087
+281,995
+33% +$9.77M 0.01% 659
2024
Q1 		$37.2M Buy
+848,092
New +$34.6M 0.01% 667

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Franklin Resources's CGON Position: Q2 2026 in Review

Franklin Resources reduced its CG Oncology (CGON) stake by 13% in Q2 2026, selling an estimated $12.7M and leaving 1,312,880 shares worth $93.3M. The position accounts for 0.02% of the portfolio, ranked #480.

Franklin Resources first reported a position in CGON in Q1 2024 and has held it in 10 quarters since. The position peaked at $102M in Q1 2026. 228 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • Franklin Resources held 1,312,880 shares of CG Oncology worth $93.3M as of Q2 2026.
  • Franklin Resources sold 194,125 CG Oncology shares in Q2 2026, an estimated $12.7M.
  • CG Oncology made up 0.02% of Franklin Resources's portfolio in Q2 2026, its #480 holding.
  • Franklin Resources first reported a position in CG Oncology in Q1 2024 and has held it in 10 quarters since.
  • Franklin Resources's CG Oncology position peaked at $102M in Q1 2026.
  • 228 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.